Kimberly-Clark Launches New Product Safety Study
Kimberly-Clark (KMB) announced the launch of a new clinical trial, 'An Open-Label Applicator Tampon Safety-in-Use Study,' to evaluate product safety and reinforce consumer trust in its feminine care division. The company also reaffirmed its commitment to core products through the Huggies campaign on May 6, 2026, and declared a regular quarterly dividend of $1.28 per share.
Tickers: $KMB